Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

AFX.DE

Buy

Carl Zeiss Meditec AG · Healthcare · Germany · $3.3B · Avg Vol: $11M/d

77
StockRank
Get insider-trade alerts
Q
65
V
58
M
49
P/E (TTM)
22.8x
ROE
6.7%
D/E
0.3x
Dividend %
1.7%
Dir. Trades · 180d
None →
Buybacks · 180d
None →

COMPANY DESCRIPTION

Carl Zeiss Meditec AG is a leading medical technology company specializing in ophthalmic and microsurgery devices, systems, and consumables. Its competitive advantage is secured by a prestigious brand reputation, a vast global installed base, and high switching costs associated with specialized surgical training. The company is a dominant market leader in the high-margin refractive laser surgery and cataract treatment spaces.

FINANCIAL SUMMARY (EUR)

Year2022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue1.9B2.1B2.1B2.2B5.4%2.2B2.2B2.3B1.3%
EPS (EUR)3.293.252.011.61-21.2%1.381.351.55-1.8%
Shares89.4M89.4M87.5M87.5M-2.1%87.5M———
Debt127.9M155.7M151.3M132.5M1.2%584.9M———
Equity2.0B2.2B2.0B2.1B1.7%————
Op CF188.2M250.9M247.3M209.9M3.7%206.0M———
Inv CF-92.9M-111.0M-412.3M-91.0M—————
Fin CF-94.2M-135.1M176.2M-108.8M—————
Loading 1Y...
PRICE (1Y)+7.3%
31.6833.1734.6636.1537.64Jul 16Aug 6Aug 27
SMA 50SMA 200

Close
$37.29
RSI (14)
61.9
52W High
$54.80
From 52W High
0.7%

SCORE BREAKDOWN

Quality
65
ROIC
6.8%63.5
ROE
6.7%61.9
GP/Assets
33.9%71.4
Op. Margin
11.1%67.1
FCF/Assets
3.9%64.4
Piotroski
894.2
Int. Cover
7.2x57.8
D/E Ratio
0.28x43.7
Current Ratio
2.34x45.7
Value
58
P/E (TTM)
22.8x52.8
EV/EBITDA
15.0x47.3
P/FCF
21.8x59.2
P/B
1.3x76.6
P/S
1.3x79.3
Div Yield
1.7%42.7
Momentum
49
52W High %
68%45.9
RS 6M
17%78.3
SMA 50/200
0.98x54.1
EPS Rev 4W
-10.3%9.4
EPS Rev 12W
-16.5%8.8
EPS Improve
+13%30.9
Q Growth
94%83.3

FUNDAMENTALS

Market Cap
$3.3B
P/E (Forward)
20.1x
Gross Margin
51.6%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AFX.DE are excluded.

TickerCompanyMkt CapStockRankSignal
AFX.DECarl Zeiss Meditec AG(you)$3.3B77Buy
FIE.DEFielmann Group AG$3.9B77Buy
GXI.DEGerresheimer AG$1.1B56Hold
SRT.DESartorius Aktiengesellschaft$15.5B58Hold
NNNNAnbio Biotechnology$347M18Strong Sell
DMP.DEDermapharm Holding SE$2.3B94Strong Buy
EUZ.DEEckert & Ziegler SE$962M79Buy
DRW3.DEDrägerwerk AG & Co. KGaA$2.4B99Strong Buy
RHK.DERHÖN-KLINIKUM Aktiengesellschaft$1.1B89Strong Buy
FME.DEFresenius Medical Care AG$12.5B94Strong Buy

Peer medians: ROE 7.2% · P/E 16.5x · Gross margin 45.4%

Carl Zeiss Meditec AG (AFX.DE): Stock Score Summary

Carl Zeiss Meditec AG (AFX.DE) has a MoatMap StockRank of 77/100 based on Quality (65/100), Value (58/100), and Momentum (49/100) factor scores. The current signal is BUY.

Carl Zeiss Meditec AG is a leading medical technology company specializing in ophthalmic and microsurgery devices, systems, and consumables. Its competitive advantage is secured by a prestigious brand reputation, a vast global installed base, and high switching costs associated with specialized surgical training. The company is a dominant market leader in the high-margin refractive laser surgery and cataract treatment spaces.

Key Financial Metrics

Price$37.29
Market Cap$3.3B
P/E (TTM)22.83
P/E (Forward)20.13
Price/Book1.30
Return on Equity6.7%
Return on Invested Capital6.8%
Debt/Equity0.28x
Gross Margin51.6%
Operating Margin11.1%
Revenue Growth2.4%
Dividend Yield1.7%
Free Cash Flow$152M

Carl Zeiss Meditec AG operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (Germany).

Frequently Asked Questions

What is Carl Zeiss Meditec AG’s (AFX.DE) StockRank?
MoatMap’s StockRank for Carl Zeiss Meditec AG (AFX.DE) is 77/100, with a Buy signal. It is a composite of Quality (65), Value (58), and Momentum (49) factor ranks across MoatMap’s 20,000+ stock universe.
Does Carl Zeiss Meditec AG have an economic moat?
Carl Zeiss Meditec AG (AFX.DE) has a Quality factor score of 65/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Carl Zeiss Meditec AG a buy, hold, or sell?
MoatMap’s current signal for Carl Zeiss Meditec AG (AFX.DE) is Buy, based on a StockRank of 77/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Carl Zeiss Meditec AG in?
Carl Zeiss Meditec AG (AFX.DE) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (Germany).
Browse all ranked stocksAFX.DE deep dive reportAI ChampionsHow we score stocksSense-check another stock